Company: NCEL
Filing Date: 2025-10-17
Form Type: POS AM
Source: 0001213900-25-099986
Chunk: 6

Company: NewcelX Ltd.
Filing Date: 2025-10-17
Form: POS AM
Chunk 6
---
, developments and business decisions to differ materially from those anticipated in these forward -lookingstatements include, but are not limited to, statements about: •the ability of NLS and Kadimastem to consummate the Merger; •the risks that the consummation of the Merger is substantially delayed or does not occur, for example due to the failure to obtain shareholder approval; •the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement; •the expected benefits of the Merger; •the unexpected costs related to the proposed Merger; •the financial and business performance of NLS, including financial projections and business metrics and any underlying assumptions thereunder; •changes in NLS’s and Kadimastem’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; •the implementation, market acceptance and success of NLS’s and Kadimastem’s business model; •NLS’s and Kadimastem’s ability to scale in a cost -effectivemanner; •developments and projections relating to NLS’s and Kadimastem’s competitors and industry; •NLS’s and Kadimastem’s expectations regarding its ability to obtain and maintain intellectual property protection and not infringe on the rights of others; •expectations regarding the time during which NLS will be an EGC under the JOBS Act; •NLS’s and Kadimastem’s future capital requirements and sources and uses of cash; •NLS’s and Kadimastem’s ability to obtain funding for their operations; •NLS’s and Kadimastem’s business, expansion plans and opportunities; •NLS’s and Kadimastem’s management and board of directors; 2 •the listing of NLS’s securities on Nasdaq; •geopolitical risk and changes in applicable laws or regulations; •fluctuations in exchange rates between the foreign currencies in which NLS and Kadimastem typically do business and the United States dollar; and •the outcome of any known and unknown litigation and regulatory proceedings. The foregoing list is intended to identify only certain of the principal factors that could cause actual results to differ. For a more detailed description of the risks and uncertainties affecting our company, reference is made to the Annual Report, which was filed with the SEC, on May 16, 2025, and the other risk factors discussed from time to time by our company in reports filed or furnished to the SEC